Search by Drug Name or NDC
NDC 37000-0448-12 Vicks 10; 200 mg/15mL; mg/15mL Details
Vicks 10; 200 mg/15mL; mg/15mL
Vicks is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by The Procter & Gamble Manufacturing Company. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 37000-0448-12Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 37000-0448-12Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
NDC | 37000-0448 |
---|---|
Product ID | 37000-448_eac4e3bf-2155-e120-e053-2a95a90affe9 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Vicks |
Proprietary Name Suffix | Formula 44 Cough and Chest Congestion |
Non-Proprietary Name | Dextromethorphan Hydrobromide, Guaifenesin |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | ORAL |
Active Ingredient Strength | 10; 200 |
Active Ingredient Units | mg/15mL; mg/15mL |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
Labeler Name | The Procter & Gamble Manufacturing Company |
Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | M012 |
Listing Certified Through | 2023-12-31 |
Package
Package Images

NDC 37000-0448-12 (37000044812)
NDC Package Code | 37000-448-12 |
---|---|
Billing NDC | 37000044812 |
Package | 354 mL in 1 BOTTLE, PLASTIC (37000-448-12) |
Marketing Start Date | 2017-07-11 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 4e77a097-eb35-4d14-e054-00144ff88e88 Details
Uses
Warnings
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- cough that occurs with too much phlegm (mucus)
- a sodium-restricted diet
Directions
Inactive ingredients
PRINCIPAL DISPLAY PANEL - 354 ml Bottle Label
INGREDIENTS AND APPEARANCE
VICKS
FORMULA 44 COUGH AND CHEST CONGESTION
dextromethorphan hydrobromide, guaifenesin liquid |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
|
Labeler - The Procter & Gamble Manufacturing Company (004238200) |